SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001085146-02-000179
Filing Date
2002-11-07
Accepted
2002-11-07 17:15:19
Documents
1

Document Format Files

Seq Description Document Type Size
1 GLFD - DURUS glfd13ga1110702.txt SC 13G/A 18750
  Complete submission text file 0001085146-02-000179.txt   20495
Mailing Address
Business Address 6611 TRIBUTARY ST BALTIMORE MD 21224 4106316300
GUILFORD PHARMACEUTICALS INC (Subject) CIK: 0000918066 (see all company filings)

IRS No.: 521841960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-46794 | Film No.: 02813037
SIC: 2834 Pharmaceutical Preparations

Mailing Address 113 POST RD. EAST WESTPORT CT 06880
Business Address 113 POST RD. EAST VESTPORT CT 06880 2033410667
DURUS CAPITAL MANAGEMENT (Filed by) CIK: 0001166014 (see all company filings)